Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
128 participants
OBSERVATIONAL
2016-09-01
2020-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center
NCT05095948
Assessing the Patient Experience in Cancer Care
NCT01621295
Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs
NCT01346280
Evaluating the Impact of Patient-Centered Oncology Care
NCT02110758
Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer
NCT00037024
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1
Current smokers with cancer who are planning to get radiation therapy at MUSC.
Survey
Subjects will be asked to complete a survey asking questions about his/her current health, well-being and quality of life.
Saliva sample
Subjects will have saliva collected by a member of the study team using a cotton swab.
Smoking Status questions
Subjects will be asked to complete an assessment asking questions about his/her current smoking status
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey
Subjects will be asked to complete a survey asking questions about his/her current health, well-being and quality of life.
Saliva sample
Subjects will have saliva collected by a member of the study team using a cotton swab.
Smoking Status questions
Subjects will be asked to complete an assessment asking questions about his/her current smoking status
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 21 years of age or older at time of study registration
* Must have been referred to MUSC radiation oncology for treatment with curative radiation therapy
* Must report current smoking defined as self-reporting smoking within the past 30 days using a structured intake questionnaire.
Exclusion Criteria
* Patients that have other cancer disease types will be excluded due to either significant differences in standard radiation therapy approaches or rarity of disease required radiation.
* Patients who are currently participating in the Medical University of South Carolina Hollings Cancer Center smoking cessation program
* Patients who are unable to provide informed consent
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
Medical University of South Carolina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Graham Warren, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Medical University of South Carolina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of South Carolina
Charleston, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
102472
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.